Related Experiment Video
Updated: Aug 10, 2026

Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish
Published on: December 26, 2014
Transplantable tumor lines generated in clonal zebrafish
Igor V Mizgireuv1, Sergei Y Revskoy
1Laboratory of Genetic Toxicology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia.
Abstract:
Transplantable zebrafish tumors are a novel and very promising model in cancer research. However, further progress in this field has been contained by a lack of true inbred lines in zebrafish. To overcome this problem, we generated two lines of homozygous diploid clonal zebrafish lines (i.e., CB1 and CW1), which allowed us to carry out transplantation of any tissue, including tumors, from one fish to another within a line without rejection of the graft. The primary tumors in CB1 fish were induced by N-nitrosodiethylamine (DEN). The histologic analysis of these tumors revealed different types of hepatocellular carcinomas, hepatoblastomas, hepatoma, cholangiocarcinoma, and pancreatic carcinoma. Four spontaneous acinar cell carcinomas of pancreas were also found in 10- to 18-month-old CB1 fish. Small pieces of tissue or cell suspensions of either DEN-induced or spontaneous tumors were serially transplanted into the peritoneal cavity of syngeneic fish at different stages of development from 5-day-old larvae to adult fish. The development of grossly visible tumors occurred from 2 weeks to 3 months after tumor grafting and grew either as solitary smooth nodules or as an amorphous jelly-like mass infiltrating abdominal organs. The majority of tumors were also successfully transplanted to isogeneic (F1 generation from crossing CB1 x CW1) fish. At the present time, 19 transplantable zebrafish tumor lines have been generated and maintained for as long as 3 to 25 passages. This model provides a novel tool for studying experimental tumor biology and therapy and will become a cost effective system for high throughput screening of anticancer drugs.
Insights
Researchers developed transplantable zebrafish tumor models using novel clonal lines (CB1 and CW1). This breakthrough enables graft acceptance, advancing cancer research and drug screening with these promising zebrafish models.
Area of Science:
- Zebrafish cancer research
- Transplantable tumor models
- Inbred zebrafish lines
Background:
- Transplantable zebrafish tumors are a promising cancer research model.
- Progress has been limited by the absence of true inbred zebrafish lines, hindering graft acceptance.
Purpose of the Study:
- To generate homozygous diploid clonal zebrafish lines for successful tumor transplantation.
- To establish a robust model for studying experimental tumor biology and therapy.
Main Methods:
- Generated two homozygous diploid clonal zebrafish lines (CB1 and CW1).
- Induced primary tumors in CB1 fish using N-nitrosodiethylamine (DEN) and identified spontaneous tumors.
- Serially transplanted tumor tissues and cell suspensions into syngeneic and isogeneic zebrafish.
- Histologic analysis of induced and transplanted tumors.
Main Results:
- Successfully generated 19 transplantable zebrafish tumor lines, maintained for 3-25 passages.
- Demonstrated successful tumor grafting and growth in syngeneic and isogeneic fish without rejection.
- Observed development of various tumor types including hepatocellular carcinomas and pancreatic carcinomas.
- Tumor development occurred within 2 weeks to 3 months post-grafting.
Conclusions:
- The developed clonal zebrafish lines overcome previous transplantation barriers.
- These transplantable tumor models offer a novel tool for experimental cancer biology.
- The system is cost-effective for high-throughput screening of anticancer drugs.
More Related Videos
09:43Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response
Published on: May 17, 2017
06:10A Simple, Rapid, and Effective Method for Tumor Xenotransplantation Analysis in Transparent Zebrafish Embryos
Published on: July 12, 2024